Renatus is an early-stage biotech company dedicated to developing innovative therapies that directly target and reverse cellular cholesterol accumulation—a key hallmark of various age-related and metabolic diseases. The company's diverse pipeline encompasses a wide range of therapeutic areas, including chronic kidney disease, atherosclerosis, Alzheimer's disease, Niemann-Pick Type C disease, metabolic-associated steatohepatitis (MASH), and cancer.
At the core of Renatus’s approach is the selective targeting of excess cholesterol, particularly within lysosomes, without disrupting cholesterol essential for normal cellular processes. This innovation addresses a critical challenge in cholesterol-targeting therapies: while cholesterol is vital for numerous physiological functions and is ubiquitous in cells, its abnormal accumulation in specific compartments, such as lysosomes, drives the progression of many diseases. Traditional cholesterol-targeting strategies often interfere with normal cholesterol functions, leading to significant adverse effects.
Importantly, the removal of lysosomal cholesterol induces effects beyond simply lowering cholesterol levels. It reprograms key cellular pathways, including mitochondrial homeostasis, lipid synthesis and metabolism, inflammation regulation, and cell survival mechanisms.
By addressing abnormal cholesterol accumulation, Renatus’s technology has the potential to improve cellular health, restore lipid metabolism, and transform the treatment landscape for diseases such as atherosclerosis, chronic kidney disease, Alzheimer's disease, and more.
Company Details
- Founded
- -
- Address
- Daejeon, Yuseong-Gu 34013, Kr
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://renatustx.com
- HQ
- Daejeon, Yuseong-gu
Renatus Questions
Renatus's website is http://renatustx.com
Renatus's LinkedIn profile is https://kr.linkedin.com/company/renatustx
Renatus's industry is
Pharmaceutical Manufacturing
Renatus's top competitors are
Amtixbio,
Dongkook Pharmaceutical Co Ltd,
Bioneex,
Carbohyde,
The Movement Laboratory Pte Ltd,
Glycoscience Inc,
Chembind Glycoscience,
Aventine,
European Biopharma Therapeutics,
Glycomira Therapeutics, Inc..
Renatus's categories are Pharmaceutical Manufacturing
Renatus's founding year is 2021
